16 insiders reported 247 Form 4 transactions for Revolution Medicines, Inc. (RVMD) over the past 18 months (most recent 2026-09-24). Recent activity: ANDERSON ELIZABETH M (Director) Buy 5,070 shares, ANDERSON ELIZABETH M (Director) Sell 910 shares, ANDERSON ELIZABETH M (Director) Sell 4,985 shares, ANDERSON ELIZABETH M (Director) Sell 2,648 shares, ANDERSON ELIZABETH M (Director) Sell 1,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Buy | 5,070 | $5,678 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 910 | $174,585 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 4,985 | $959,805 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 2,648 | $512,227 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 1,500 | $291,883 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 100 | $19,515 |
| 2026-09-22 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 1,764 | $347,402 |
| 2026-09-18 | Cislini Jeff | SVP & General Counsel | Sell | 52 | $10,140 |
| 2026-09-18 | Horn Margaret A | Chief Operating Officer | Sell | 76 | $14,821 |
| 2026-09-18 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 85 | $16,576 |
| 2026-09-18 | Anders Jack | Chief Financial Officer | Sell | 61 | $11,895 |
| 2026-09-18 | Sandler Alan B. | Chief Development Officer | Sell | 5 | $975 |
| 2026-09-18 | GOLDSMITH MARK A | President and Chief Executive Officer | Sell | 213 | $41,537 |
| 2026-09-18 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 27 | $5,266 |
| 2026-09-18 | GOLDSMITH MARK A | President and Chief Executive Officer | Sell | 13,775 | $2.7M |
| 2026-09-18 | Horn Margaret A | Chief Operating Officer | Sell | 4,891 | $974,792 |
| 2026-09-18 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 5,484 | $1.1M |
| 2026-09-18 | Anders Jack | Chief Financial Officer | Sell | 3,992 | $795,618 |
| 2026-09-18 | Sandler Alan B. | Chief Development Officer | Sell | 336 | $66,966 |
| 2026-09-18 | Cislini Jeff | SVP & General Counsel | Sell | 3,314 | $660,491 |
| 2026-09-18 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 1,747 | $348,183 |
| 2026-09-15 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Buy | 52,500 | $2.2M |
| 2026-09-15 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Buy | 40,031 | $1.6M |
| 2026-09-15 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 800 | $158,840 |
| 2026-09-15 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 11,833 | $2.4M |
来源：SEC Form 4 申报文件 · 截至 2026-09-24